Nyheter/rapporter

Senaste pressmeddelanden och rapporter för bevakat bolag.

Datum Källa Rubrik Typ Alternativ
2024-05-20 Penser Access by Carnegie Penser Access by Carnegie: Intervacc: Positiva signaler i Sverige Pressreleaser Visa Stäng
2024-05-15 Intervacc Kommuniké från årsstämman i Intervacc AB (publ) Pressreleaser Ladda ner | Visa Stäng
2024-05-15 Intervacc Report from Annual General Meeting in Intervacc Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 15 May 2024 | Intervacc

Report from Annual General Meeting in Intervacc

Adoption of the income statement and balance sheet

The AGM adopted the Board of Directors’ submitted income statement and balance sheet for the parent company and the group for the financial year 2023.

Appropriation of the company’s profit or loss

The AGM resolved, in accordance with the Board of Directors’ proposal, that no dividend shall be paid for the financial year 2023, and that the result shall be balanced in a new account.

Discharge from liability towards the members of the Board of Directors and the CEOs

The AGM resolved to discharge each of the members of the Board of Directors and the CEOs who have been active during the financial year 2023, from liability for the financial year 2023.

Board of Directors and auditor

The AGM resolved, in accordance with the Nomination Committee’s proposal, that the Board of Director shall consist of seven Board members without any deputies.

The AGM resolved, in accordance with the Nomination Committee’s proposal, to re-elect Håkan Björklund, Lisen Bratt Fredricson, Jan-Ingmar Flock, Lennart Johansson och Camilla Ramfelt McCarthy, and to elect Mathias Uhlen and Emil Billbäck, as Board members for the period up to and including the next AGM. Håkan Björklund was re-elected as the Board of Directors’ chairperson for the period up to and including the next AGM.

The AGM resolved, in accordance with the Nomination Committee’s proposal, that the fees to the Board of Directors shall be paid with SEK 280,000 to the Board of Directors’ chairperson and SEK 130,000 to each of the other Board members.

The AGM resolved, in accordance with the Nomination Committee’s proposal, to re-elect the registered public accounting firm Öhrlings PricewaterhouseCoopers AB as the company’s auditor for the period up to and including the next AGM, which intends to appoint the authorised public accountant Niclas Bergenmo as auditor in charge.

The AGM resolved that fees to the auditor shall be paid according to the current account.

Authorisation regarding issues

The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board of Directors, within the limits of the Articles of Association, with or without deviation from the shareholders’ preferential rights, on one or more occasions, until the next AGM, to resolve to increase the company’s share capital through issues of new shares, warrants and/or convertibles in the company. The total number of shares covered by such new issues may correspond to a total of no more than ten (10) percent of the shares in the company at the time of the AGM 2024.

Amendment of the Articles of Association regarding the limits of the share capital, and reduction of the share capital for allocation to non-restricted equity

The AGM resolved, in accordance with the Board of Directors’ proposal, to change the Articles of Association’s paragraph 4 regarding the limits for the share capital to not less than SEK 8,000,000 and not more than SEK 32,000,000, and on a reduction of the share capital by SEK 136,325,285.444635, without retirement of shares, for allocation to non-restricted equity.

For more information please contact:

Jonas Sohlman, CEO

Phone: +46 (0)8 120 10600

E-mail: jonas.sohlman@intervacc.se

The information was submitted for publication, through the agency of the contact person set out above on May 15, 2024, 14.30 CET.

About Intervacc

Intervacc AB is a Swedish company within animal health developing vaccines for animals. The Company’s vaccine and vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the Company’s research and development work. The Intervacc share has been listed on the NASDAQ First North Growth Market since April 2017 with Eminova Fondkommission AB as Certified Adviser.

Contact information for Certified Adviser

Eminova Fondkommission AB

E-mail: adviser@eminova.se,Phone: +46 (0)8 – 684 211 10

2024-05-15 Intervacc Intervacc: Delårsrapport januari - mars 2024 Rapporter Ladda ner | Visa Stäng
2024-05-15 Intervacc Intervacc: Interim report January - March 2024 Rapporter Ladda ner | Visa Stäng
2024-04-15 Intervacc Notice of Annual General Meeting in Intervacc AB (publ) Pressreleaser Ladda ner | Visa Stäng
2024-04-15 Intervacc Kallelse till årsstämma i Intervacc AB (publ) Pressreleaser Ladda ner | Visa Stäng
2024-04-10 Intervacc Intervacc publishes the 2023 Annual Report Pressreleaser Ladda ner | Visa Stäng
2024-04-10 Intervacc Intervacc publicerar årsredovisning för 2023 Pressreleaser Ladda ner | Visa Stäng
2024-03-04 Intervacc Intervacc announces changes in the Nomination Committee Pressreleaser Ladda ner | Visa Stäng
2024-03-04 Intervacc Intervacc offentliggör förändringar i valberedningen Pressreleaser Ladda ner | Visa Stäng
2024-02-28 Intervacc Jonas Sohlman ny VD för Intervacc AB Pressreleaser Ladda ner | Visa Stäng
2024-02-28 Intervacc Jonas Sohlman appointed as new CEO for Intervacc Pressreleaser Ladda ner | Visa Stäng
2024-02-22 Intervacc Intervacc announces changes in dates for AGM and report for the first quarter 2024 Pressreleaser Ladda ner | Visa Stäng
2024-02-22 Intervacc Intervacc tidigarelägger årsstämma och rapport för första kvartalet 2024 Pressreleaser Ladda ner | Visa Stäng
2024-02-21 Penser Access by Carnegie Penser Access by Carnegie: Intervacc - Behöver visa tillväxt Pressreleaser Visa Stäng
2024-02-16 Intervacc Intervacc: Bokslutskommuniké januari - december 2023 Pressreleaser Ladda ner | Visa Stäng
2024-02-16 Intervacc Intervacc: Year-end report January - December 2023 Pressreleaser Ladda ner | Visa Stäng
2024-02-13 Intervacc Intervacc: Invitation to conference call and audiocast in connection with the year-end report Pressreleaser Ladda ner | Visa Stäng
2024-02-13 Intervacc Intervacc: Inbjudan till telefonkonferens och audiocast i samband med bokslutskommuniké Pressreleaser Ladda ner | Visa Stäng
2024-02-07 Intervacc Intervaccs tilldelas prestigefullt bidrag från Eurostars för vidareutveckling av sitt prototypvaccin till gris Pressreleaser Ladda ner | Visa Stäng
2024-02-07 Intervacc Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs Pressreleaser Ladda ner | Visa Stäng
2023-12-21 Intervacc Förändringar av valberedningen i Intervacc Pressreleaser Ladda ner | Visa Stäng
2023-12-21 Intervacc Intervacc announces changes in the Nomination Committee Pressreleaser Ladda ner | Visa Stäng
2023-12-11 Intervacc Intervacc: Europas ledande experter inom kvarka träffas vid riksanläggningen i Flyinge för att dela de senaste framstegen kring smittskydd och vaccination Pressreleaser Ladda ner | Visa Stäng
2023-12-11 Intervacc Intervacc: The National Equestrian Centre at Flyinge to host European expert meeting on the use of vaccination to prevent strangles in horses Pressreleaser Ladda ner | Visa Stäng
2023-11-23 Intervacc Report from Extraordinary General Meeting in Intervacc Pressreleaser Ladda ner | Visa Stäng
2023-11-23 Intervacc Kommuniké från extra bolagsstämma i Intervacc Pressreleaser Ladda ner | Visa Stäng
2023-11-22 Intervacc Intervacc beviljas patent i USA för vaccin mot infektioner orsakade av Streptococcus suis Pressreleaser Ladda ner | Visa Stäng
2023-11-22 Intervacc U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus suis Pressreleaser Ladda ner | Visa Stäng
2023-11-17 Penser Access Penser Access: IVACC Q3 2023 - Intervacc Pressreleaser Visa Stäng
2023-11-16 Intervacc Intervacc: Interim report January - September 2023 Rapporter Ladda ner | Visa Stäng
2023-11-16 Intervacc Intervacc: Delårsrapport januari - september 2023 Rapporter Ladda ner | Visa Stäng
2023-11-15 Intervacc Inbjudan till webcast i samband med Intervaccs delårsrapport för tredje kvartalet, 2023 Pressreleaser Ladda ner | Visa Stäng
2023-11-15 Intervacc Invitation to conference call with presentation of Intervacc's Interim report for the third quarter, 2023 Pressreleaser Ladda ner | Visa Stäng
2023-10-30 Intervacc Nomination Committee appointed in Intervacc Pressreleaser Ladda ner | Visa Stäng
2023-10-30 Intervacc Valberedning utsedd i Intervacc Pressreleaser Ladda ner | Visa Stäng
2023-10-19 Intervacc Intervacc: NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTERVACC AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-10-19 Intervacc Intervacc: KALLELSE TILL EXTRA BOLAGSSTÄMMA I INTERVACC AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-09-01 Penser Access Penser Access: IVACC Q2’23 - Intervacc Pressreleaser Visa Stäng
2023-08-31 Intervacc Intervacc: Delårsrapport januari - juni 2023 Rapporter Ladda ner | Visa Stäng
2023-08-31 Intervacc Intervacc: Interim report January - June 2023 Rapporter Ladda ner | Visa Stäng
2023-08-21 Intervacc Andreas Andersson steps down as President and CEO. Jonas Sohlman has been appointed acting President and CEO for Intervacc Pressreleaser Ladda ner | Visa Stäng
2023-08-21 Intervacc Andreas Andersson slutar som VD och koncernchef - Jonas Sohlman har utsetts som tillförordnad VD och koncernchef för Intervacc Pressreleaser Ladda ner | Visa Stäng
2023-08-17 Intervacc Intervacc awarded grant to optimise production processes for a fusion protein, which is one component of a prototype vaccine for pigs Pressreleaser Ladda ner | Visa Stäng
2023-08-17 Intervacc Intervacc beviljas bidrag för att utveckla tillverkningsprocessen för ett prototypvaccin för grisar Pressreleaser Ladda ner | Visa Stäng
2023-07-11 Intervacc Intervaccs beviljas medel för uppstartsfasen i ett utvecklingsprojekt som avser att ta fram tillverkningsprocesser för ett prototypvaccin mot Streptococcus suis infektioner hos gris Pressreleaser Ladda ner | Visa Stäng
2023-07-11 Intervacc Intervacc to collaborate with Testa Center to optimise production processes for their prototype vaccine for pigs Pressreleaser Ladda ner | Visa Stäng
2023-07-10 Intervacc Intervacc ställer ut på Falsterbo Horse Show Pressreleaser Ladda ner | Visa Stäng
2023-06-08 Intervacc Intervacc offentliggör utfall i den fullt säkerställda företrädesemissionen Pressreleaser Ladda ner | Visa Stäng
2023-06-08 Intervacc Intervacc announces the outcome of the fully secured rights issue Pressreleaser Ladda ner | Visa Stäng
2023-06-07 Intervacc Kommuniké från årsstämman i Intervacc AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-06-07 Intervacc Report from Annual General Meeting in Intervacc Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

13 Jun 2024 | Årligutdelning
30 Aug 2024 | Kvartalsrapport 2024-Q2
14 Nov 2024 | Kvartalsrapport 2024-Q3
13 Feb 2025 | Bokslutskommuniké 2024